Abivax (AAVXF) Debt Ratio (2021 - 2026)
Abivax (AAVXF) posted Debt Ratio of 0.0 for Q1 2026, down 33.3% on a QoQ basis from 0.0 in Q4 2025, and down 99.63% year-over-year from 0.17 in Q1 2025.
Analysis
Abivax (AAVXF) Debt Ratio (2021 - 2026) Analysis & Trends
Abivax has reported Debt Ratio for 6 years, with the latest figure at 0.0 in Q1 2026.
- On a quarterly basis, Debt Ratio fell 99.63% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 99.63% decrease from a year earlier, with the FY2025 full-year figure at 0.0, down 94.63% from the prior year.
- Debt Ratio was 0.0 for Q1 2026 at Abivax, down from 0.0 in the prior quarter.
- The five-year high for Debt Ratio was 0.6 in Q2 2025, with the low at 0.0 in Q1 2026.
- Average Debt Ratio over 5 years is 0.13, with a median of 0.06 recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Debt Ratio jumped 265.17% in 2025, then slumped 99.63% in 2026.
- Over 5 years, Debt Ratio stood at 0.1 in 2022, then sank by 78.72% to 0.02 in 2023, then retreated by 14.8% to 0.02 in 2024, then tumbled by 94.63% to 0.0 in 2025, then sank by 33.3% to 0.0 in 2026.
- The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.06 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | - |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.02 |
| Jun 30, 2024 | 0.16 |
| Dec 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.10 |
| Dec 31, 2021 | 0.15 |